Imahashi, Kenichi

Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. [electronic resource] - Circulation research Oct 2004 - 734-41 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

1524-4571

10.1161/01.RES.0000143898.67182.4c doi


Adenosine Triphosphate--metabolism
Anaerobiosis
Animals
Apoptosis
Blotting, Western
Cytosol--chemistry
Energy Metabolism--drug effects
Female
Gene Expression Regulation
Genes, bcl-2
Glycolysis
Humans
Hydrogen-Ion Concentration
Male
Mice
Mice, Transgenic
Mitochondria, Heart--drug effects
Myocardial Contraction
Myocardial Infarction--pathology
Myocardial Ischemia--metabolism
Myocardial Reperfusion Injury--metabolism
Nuclear Magnetic Resonance, Biomolecular
Oligomycins--pharmacology
Phosphocreatine--metabolism
Porins--metabolism
Proto-Oncogene Proteins c-bcl-2--biosynthesis
Proton-Translocating ATPases--physiology
Recombinant Fusion Proteins--physiology
Voltage-Dependent Anion Channels